https://www.engineeringnews.co.za
Energy|Innovation|Nuclear|Services|Technology|Products
Energy|Innovation|Nuclear|Services|Technology|Products
energy|innovation|nuclear|services|technology|products

Necsa scientist in spotlight with award successes

2nd April 2019

By: Rebecca Campbell

Creamer Media Senior Deputy Editor

     

Font size: - +

A scientist from the South African Nuclear Energy Corporation (Necsa), Dr Jan Rijn Zeevaart, has won two prestigious awards, one local and the other international.

These are the Department of Science and Technology’s Top Intellectual Property Creator Award and the European Association of Nuclear Medicine’s (EANM’s) Marie Curie Award for best oral presentation (at its thirty-first annual conference, which was held in Dusseldorf, Germany, last October).

Dr Zeevaart, who is Necsa’s head of radiochemistry, was the corporation’s top creator of intellectual property (IP), in terms of implementable disclosures to the Office of Technology Transfer, over the period April 1, 2011, to March 31, 2018. During this time, he authored or co-authored ten Innovation Disclosures and co-authored six of Necsa’s “patent families”. All these are in the areas of radiopharmaceuticals and radiochemicals.

As the winner of the Top Intellectual Property Award, he was presented with R605 000 to fund the development of his intellectual property into products, processes or services. The aim is to develop new radioisotopes and radiopharmaceuticals which can be commercially exploited by Necsa.

“I am assured that there will be more [IP] applications going forward in the future,” highlighted Necsa acting CEO Don Robertson. He congratulated Dr Zeevaart and encouraged him to continue developing IP.

With regard to the Marie Curie Award, Dr Zeevaart was a member of an international team, with researchers from France, Sweden and Switzerland, that made a presentation to the EANM conference entitled “Terbium-161 for PSMA-Targeted Radionuclide Therapy for Prostate Cancer”. (Terbium-161 is a “new generation” – in terms of medical application – radioisotope, which permits more precise targeting of tumours for both diagnosis and treatment. PSMA stands for prostate-specific membrane antigen.)

He made a point of highlighting the assistance he had received from his colleague and fellow radiochemist, Ms Lebogang Sepini, in the development of Necsa’s input to the international team.

Edited by Creamer Media Reporter

Comments

Showroom

WearCheck
WearCheck

Leading condition monitoring specialists, WearCheck, help boost machinery lifespan and reduce catastrophic component failure through the scientific...

VISIT SHOWROOM 
Booyco Electronics
Booyco Electronics

Booyco Electronics, South African pioneer of Proximity Detection Systems, offers safety solutions for underground and surface mining, quarrying,...

VISIT SHOWROOM 

Latest Multimedia

sponsored by

Option 1 (equivalent of R125 a month):

Receive a weekly copy of Creamer Media's Engineering News & Mining Weekly magazine
(print copy for those in South Africa and e-magazine for those outside of South Africa)
Receive daily email newsletters
Access to full search results
Access archive of magazine back copies
Access to Projects in Progress
Access to ONE Research Report of your choice in PDF format

Option 2 (equivalent of R375 a month):

All benefits from Option 1
PLUS
Access to Creamer Media's Research Channel Africa for ALL Research Reports, in PDF format, on various industrial and mining sectors including Electricity; Water; Energy Transition; Hydrogen; Roads, Rail and Ports; Coal; Gold; Platinum; Battery Metals; etc.

Already a subscriber?

Forgotten your password?

MAGAZINE & ONLINE

SUBSCRIBE

RESEARCH CHANNEL AFRICA

SUBSCRIBE

CORPORATE PACKAGES

CLICK FOR A QUOTATION







sq:0.127 0.178s - 168pq - 2rq
Subscribe Now